デフォルト表紙
市場調査レポート
商品コード
1603420

接着バリアの市場規模、シェア、成長分析、製品別、用途別、製剤別、地域別 - 産業予測、2024年~2031年

Adhesion Barrier Market Size, Share, Growth Analysis, By Product (Synthetic, Natural), By Application (Gynecological Surgeries, Cardiovascular Surgeries), By Formulation (Film, Liquid) By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
接着バリアの市場規模、シェア、成長分析、製品別、用途別、製剤別、地域別 - 産業予測、2024年~2031年
出版日: 2024年11月27日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の接着バリアの市場規模は、2022年に6億4,000万米ドルとなり、2023年の6億8,000万米ドルから、2031年までには11億5,000万米ドルに成長し、予測期間(2024年~2031年)のCAGRは0.68%で成長する見通しです。

世界の接着バリア市場は、手術件数の増加、スポーツ関連傷害の増加、世界のヘルスケア支出の増加を背景に、大きく成長する見通しです。外科手術の急増を反映して、接着バリアの需要は整形外科手術や心臓手術で特に高いです。米国では、サイクリングやレクリエーション・スポーツのような活動でかなりの怪我をするため、外科的ソリューションの必要性がさらに高まっています。新興諸国における急速なヘルスケアの進歩は、人口の増加と可処分所得の増加と相まって、市場の拡大を促進すると予想されます。しかし、この市場は、外科手術の高額な費用、接着バリアの潜在的な副作用、技術革新と広範な採用を妨げる厳しい規制枠組みなどの課題に直面しています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーター分析と影響
    • 競争企業間の敵対関係
    • 代替品の脅威
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 供給企業の交渉力

主要な市場の考察

  • 主要な成功要因
  • 競合の程度
  • 主要な投資機会
  • 市場エコシステム
  • 技術の進歩
  • 規制情勢
  • 特許分析
  • バリューチェーン分析
  • ケーススタディ分析
  • 顧客と購買基準の分析
    • PESTEL分析
  • 市場の魅力指数
  • 価格分析

世界の接着バリア市場規模:製品別・CAGR(2024年~2031年)

  • 市場概要
  • 合成接着バリア
    • ヒアルロン酸
    • 再生セルロース
    • ポリエチレングリコール
    • その他
  • 天然接着バリア
    • コラーゲン
    • フィブリン

世界の接着バリア市場規模:用途別・CAGR(2024年~2031年)

  • 市場概要
  • 一般外科 / 腹部外科
  • 婦人科手術
  • 心臓血管手術
  • 整形外科手術
  • 神経外科
  • その他

世界の接着バリア市場規模:製剤別・CAGR(2024年~2031年)

  • 市場概要
  • 液体
  • ゲル

世界の接着バリア市場規模・CAGR(2024年~2031年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主要な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2023年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2021年~2023年)

主要企業プロファイル

  • Baxter International Inc.(United States)
  • Anika Therapeutics, Inc.(United States)
  • Sanofi SA(France)
  • Medtronic plc(Ireland)
  • Integra LifeSciences Corporation(United States)
  • Atrium Medical Corporation(Getinge AB)(United States)
  • FzioMed, Inc.(United States)
  • MAST Biosurgery AG(Switzerland)
  • Terumo Corporation(Japan)
  • Johnson & Johnson(United States)
  • Becton, Dickinson and Company(United States)
  • B. Braun Melsungen AG(Germany)
  • Ferring Pharmaceuticals(Switzerland)
  • Adhesion Barrier Company(United States)
  • Fidia Farmaceutici S.p.A.(Italy)
  • Innocoll Holdings PLC(Ireland)
  • Biom'Up SAS(Zimmer Biomet Holdings, Inc.)(France)
  • Aziyo Biologics, Inc.(United States)

結論と提言

目次
Product Code: SQMIG15B2076

Global Adhesion Barrier Market size was valued at USD 0.64 billion in 2022 and is poised to grow from USD 0.68 billion in 2023 to USD 1.15 billion by 2031, growing at a CAGR of 0.68% during the forecast period (2024-2031).

The global Adhesion Barrier Market is poised for significant growth, driven by the rising number of surgeries, increasing sports-related injuries, and growing healthcare expenditure worldwide. The demand for adhesion barriers is particularly high in orthopedic and cardiac procedures, reflecting the surge in surgical interventions. In the United States, activities like cycling and recreational sports result in substantial injuries, further fueling the need for surgical solutions. Rapid healthcare advancements in developing countries, coupled with population growth and increased disposable incomes, are expected to enhance market expansion. However, the market faces challenges, including the high cost of surgical procedures, potential side effects of adhesion barriers, and stringent regulatory frameworks that hinder technological innovation and broader adoption.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Adhesion Barrier market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Adhesion Barrier Market Segmental Analysis

Global Adhesion Barrier Market is segmented by Product, Application, Formulation and region. Based on Product, the market is segmented into Synthetic Adhesion Barriers, (Hyaluronic Acid, Regenerated Cellulose, Polyethylene Glycol, and Other Synthetic Adhesion Barriers) and Natural Adhesion Barriers (Collagen and Fibrin)), Based on Application, the market is segmented into General/Abdominal Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, and Others. Based on Formulation, the market is segmented into Film, Liquid, and Gel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Adhesion Barrier Market

The global adhesion barrier market is driven by the rising number of surgical procedures across various domains, including general/abdominal, gynecological, cardiovascular, orthopedic, and neurological surgeries. This growing surgical volume escalates the need for effective adhesion barriers to minimize postoperative complications and adhesion formation. Additionally, heightened awareness among healthcare professionals and patients about the severe consequences of adhesions-such as pain, bowel obstruction, infertility, and organ dysfunction-further boosts demand. Technological advancements in adhesion barrier formulations, including synthetic solutions offering enhanced efficacy, biocompatibility, and extended durability, also play a crucial role in market expansion. These innovations not only improve surgical outcomes but also encourage the adoption of adhesion barriers, solidifying their importance in modern medical practices.

Restraints in the Global Adhesion Barrier Market

A significant restraint for the global adhesion barrier market is the high cost associated with these products, which limits their adoption, particularly in price-sensitive regions. Adhesion barriers, often used in surgical procedures to prevent post-operative adhesions, can significantly increase overall treatment costs, making them less accessible for patients and healthcare facilities with constrained budgets. Additionally, the stringent regulatory approval processes for medical devices in various regions can delay market entry for new adhesion barrier products, further hindering growth. Limited awareness among healthcare professionals and patients regarding the long-term benefits of adhesion barriers also contributes to lower adoption rates, particularly in emerging markets. This creates challenges for manufacturers to achieve widespread penetration and expand their market share globally.

Market Trends of the Global Adhesion Barrier Market

The global Adhesion Barrier Market is witnessing transformative trends driving its growth. A notable development is the rising adoption of bioresorbable adhesion barriers, which naturally degrade and are absorbed by the body, eliminating the need for additional surgical removal. This trend aligns with the growing demand for solutions that minimize complications and enhance patient recovery. Additionally, the market is experiencing a surge in product innovation, with companies investing heavily in research and development. These efforts focus on creating advanced adhesion barrier formulations that offer superior biocompatibility, extended efficacy, and improved usability. Together, these trends underscore the market's dynamic nature and its commitment to delivering cutting-edge solutions to meet the evolving needs of healthcare professionals and patients.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Value Chain Analysis
  • Case Study Analysis
  • Customer & Buying Criteria Analysis
    • PESTEL Analysis
  • Market Attractiveness Index
  • Pricing Analysis

Global Adhesion Barrier Market Size by Product & CAGR (2024-2031)

  • Market Overview
  • Synthetic Adhesion Barriers
    • Hyaluronic Acid
    • Regenerated Cellulose
    • Polyethylene Glycol
    • Other
  • Natural Adhesion Barriers
    • Collagen
    • Fibrin

Global Adhesion Barrier Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • General/Abdominal Surgeries
  • Gynecological Surgeries
  • Cardiovascular Surgeries
  • Orthopedic Surgeries
  • Neurological Surgeries
  • Other

Global Adhesion Barrier Market Size by Formulation & CAGR (2024-2031)

  • Market Overview
  • Film
  • Liquid
  • Gel

Global Adhesion Barrier Market Size & CAGR (2024-2031)

  • North America, (Product, Application, Formulation)
    • US
    • Canada
  • Europe, (Product, Application, Formulation)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Product, Application, Formulation)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Product, Application, Formulation)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Product, Application, Formulation)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Baxter International Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Anika Therapeutics, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Atrium Medical Corporation (Getinge AB) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FzioMed, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MAST Biosurgery AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ferring Pharmaceuticals (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Adhesion Barrier Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fidia Farmaceutici S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Innocoll Holdings PLC (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biom'Up SAS (Zimmer Biomet Holdings, Inc.) (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aziyo Biologics, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation